Compare KRYS & PCTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KRYS | PCTY |
|---|---|---|
| Founded | 2015 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 7.8B |
| IPO Year | 2017 | 2014 |
| Metric | KRYS | PCTY |
|---|---|---|
| Price | $345.86 | $153.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 11 | 17 |
| Target Price | ★ $297.60 | $176.59 |
| AVG Volume (30 Days) | 508.3K | ★ 784.6K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 128.00 | 22.39 |
| EPS | 3.62 | ★ 4.92 |
| Revenue | $389,130,000.00 | ★ $1,771,326,000.00 |
| Revenue This Year | $38.74 | $11.52 |
| Revenue Next Year | $32.53 | $7.98 |
| P/E Ratio | $93.10 | ★ $30.97 |
| Revenue Growth | ★ 33.94 | 11.04 |
| 52 Week Low | $143.09 | $92.99 |
| 52 Week High | $382.54 | $182.36 |
| Indicator | KRYS | PCTY |
|---|---|---|
| Relative Strength Index (RSI) | 54.09 | 66.12 |
| Support Level | $253.89 | $141.33 |
| Resistance Level | $382.33 | N/A |
| Average True Range (ATR) | 10.03 | 5.50 |
| MACD | 1.62 | -0.40 |
| Stochastic Oscillator | 98.36 | 84.92 |
Krystal Biotech Inc is an integrated, commercial-stage biotechnology company focused on the discovery, development, manufacturing, and commercialization of genetic medicines to treat diseases with high unmet medical needs. The company uses its patented HSV-1-based gene therapy platform to create vectors that deliver therapeutic transgenes to target cells. It possesses exclusive rights to develop, manufacture, and commercialize VYJUVEK internationally. The company operates as one operating segment focused on pharmaceutical products and manufactures, markets, and sells VYJUVEK in the United States and markets and sells VYJUVEK in the European Union, and Japan.
Paylocity is a cloud-based human capital management provider offering payroll, compliance, and human resources management solutions. With the addition of expense and IT management modules, Paylocity unifies back-office operations spanning HR, finance, and IT on a single platform and bills customers on a subscription basis. The firm's customer base skews toward the midmarket and is primarily based in the US. As of fiscal 2026, Paylocity has nearly 44,400 customers.